Bladder cancer drug developer BioClin Therapeutics, backed by Novo, has increased its latest funding round from $30m to $50m.

The Stanford-StartX has filed a lawsuit against its portfolio company MedWhat in California.

The UCSF oncological therapeutics spinout will move from California to Connecticut following a leading investment from state-owned Connecticut Innovations.

RGU expects its University Entrepreneurship Accelerator to back at least 25 projects each year in areas such as healthcare, digital and social enterprise.

Echo Health Ventures was among the series B investors as medical engagement app developer mPulse Mobile took its total funding to $25m.

The Amazon-backed baby monitor developer will use the proceeds to support the launch of two new products this year.

Amgen Ventures and M Ventures returned to reinvest in Akili Interactive Labs, a developer of game-based treatments for cognitive conditions.

The AMT, Accuron and Tianda Pharmaceuticals-backed cancer drug developer raised half of its initial target for the offering.

Based on research at Johns Hopkins University, Escient Pharmaceuticals is developing treatments for serious but unserved medical needs.

The Institute for Translational Medicine has been launched with $35m in funding from the National Institutes of Health to commercialise research from multiple universities.